These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2170718)

  • 21. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine].
    Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J
    Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination.
    Kuramoto I; Fujiyama S; Matsushita K; Sato T
    J Gastroenterol Hepatol; 1994; 9(3):228-31. PubMed ID: 8054520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers.
    Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS
    J Gastroenterol Hepatol; 1993; 8(4):338-41. PubMed ID: 8397010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
    Vidor E; Ratheau C; Briantais P; Vuillier D
    J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated hepatitis A virus vaccines.
    Lemon SM
    Hepatology; 1992 Jun; 15(6):1194-7. PubMed ID: 1317341
    [No Abstract]   [Full Text] [Related]  

  • 29. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.
    Dagan R; Greenberg D; Goldenbertg-Gehtman P; Vidor E; Briantais P; Pinsk V; Athias O; Dumas R
    Vaccine; 1999 Apr; 17(15-16):1919-25. PubMed ID: 10217590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.
    Flehmig B; Heinricy U; Pfisterer M
    Lancet; 1989 May; 1(8646):1039-41. PubMed ID: 2565998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial of a lyophilized inactivated hepatitis A candidate vaccine in healthy adult volunteers.
    Iino S; Fujiyama S; Horiuchi K; Jyo K; Kuwabara Y; Sato S; Saika S; Morita M; Odoh K; Kuzuhara S
    Vaccine; 1992; 10(5):323-8. PubMed ID: 1315469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Observation of live, attenuated hepatitis A vaccines in humans].
    Hu MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):65-8. PubMed ID: 8394801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky children.
    Block SL; Hedrick JA; Tyler RD; Smith RA; Calandra G; Patterson C; Lewis J; Sitrin R; Miller W; Schwartz S
    Pediatr Infect Dis J; 1993 Dec; 12(12):976-80. PubMed ID: 8108223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults.
    Gil A; González A; Dal-Ré R; Calero JR
    Vaccine; 1996 Aug; 14(11):1028-30. PubMed ID: 8879097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine].
    Noskova AV; Gorbunov MA; Pavlova LI; El'shina GA; Sharipova IS; Karpovich LG; Kalashnikova TI; Bektimirov TA; Rikhmer VV; El'nikov VS
    Vopr Virusol; 2000; 45(6):42-4. PubMed ID: 11200647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against hepatitis A by an inactivated vaccine.
    Innis BL; Snitbhan R; Kunasol P; Laorakpongse T; Poopatanakool W; Kozik CA; Suntayakorn S; Suknuntapong T; Safary A; Tang DB
    JAMA; 1994 May; 271(17):1328-34. PubMed ID: 8158817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.